Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: A randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 6, 2014, Pages 706-713

  Perello M F ^a   Coloma, J L ^a   Masoller, N ^a   Esteve, J ^a   Palacio, M ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ferrous sulphate; intravenous iron sucrose; postpartum anaemia

Indexed keywords

FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON; IRON SACCHARATE;

ANEMIA; ANXIETY; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON THERAPY; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MEAN CORPUSCULAR VOLUME; METALLIC TASTE; NAUSEA; POSTPARTUM ANEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SKIN TINGLING; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE;

FERROUS SULPHATE; INTRAVENOUS IRON SUCROSE; POSTPARTUM ANAEMIA;

ADMINISTRATION, ORAL; ADULT; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FERRIC COMPOUNDS; GLUCARIC ACID; HEMATINICS; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON, DIETARY; PUERPERAL DISORDERS; SEVERITY OF ILLNESS INDEX; SPAIN; TREATMENT OUTCOME;

EID: 84899444730     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12480     Document Type: Article

References (24)

1. Bodnar LM, Cogswell ME, McDonald T,. Have we forgotten the significance of postpartum iron deficiency? Am J Obstet Gynecol 2005; 193: 36-44.
2. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2012; 156: 588-600.
3. Dodd J, Dare MR, Middleton P,. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database Syst Rev 2004; CD004222.
4. Breymann C, Gliga F, Bejenariu C, Strizhova N,. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008; 101: 67-73.
5. Hallberg L, Ryttinger L, Sölvell L,. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 1966; 459: 3-10.
6. Breymann C, Richter C, Hüttner C, Huch R, Huch A,. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000; 30: 154-61.
7. Westad S, Backe B, Salvesen KA, Nakling J, Økland I, Borthen I, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand 2008; 87: 916-23.
8. Bhandal N, Russell R,. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006; 113: 1248-52.
9. Gravier A, Descargues G, Marpeau L,. How to avoid transfusion in the post-partum period: importance of an intravenous iron supplement. J Gynecol Obstet Biol Reprod (Paris) 1999; 28: 77-8.
10. Broche D-E, Gay C, Armand-Branger S, Grangeasse L, Terzibachian J-J,. Acute postpartum anaemia. Clinical practice and interest of intravenous iron. Gynecol Obstet Fertil 2004; 32: 613-9.
11. Intravenous iron therapy for correction of severe postpartum. European Journal of Anaesthesiology (EJA) [Internet]. Available from: [ http://journals.lww.com/ejanaesthesiology/Fulltext/2000/00002/ Intravenous-iron-therapy-for-correction-of-severe.503.aspx ]. Accessed 2 February 2013.
12. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G,. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fetal Neonatal Med 2013; 26: 654-9.
13. Clinical Practice Guidelines on the Use of Blood Components-(red blood cells, platelets, fresh frozen plasma, cryoprecipitate). National Health and Medical Research Council [Internet]. Available from: [ www.nhmrc.gov.au/ guidelines/publications/cp78 ]. Accessed 18 September 2012.
14. Silverman JA, Barrett J, Callum JL,. The appropriateness of red blood cell transfusions in the peripartum patient. Obstet Gynecol 2004; 104: 1000-4.
15. Atkinson LS, Baxley EG,. Postpartum fatigue. Am Fam Physician 1994; 50: 113-8.
16. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 2005; 135: 267-72.
17. Cox JL, Holden JM, Sagovsky R,. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-6.
18. Garcia-Esteve L, Ascaso C, Ojuel J, Navarro P,. Validation of the Edinburgh Postnatal Depression Scale (EPDS) in Spanish mothers. J Affect Disord 2003; 75: 71-6.
19. Grant K-A, McMahon C, Austin M-P,. Maternal anxiety during the transition to parenthood: a prospective study. J Affect Disord 2008; 108: 101-11.
20. Pedersen SS, van den Broek KC, Theuns DAMJ, Erdman RAM, Alings M, Meijer A, et al. Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int J Cardiol 2011; 147: 420-3.
21. Breymann C, Zimmermann R, Huch R, Huch A,. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. Eur J Clin Invest 1996; 26: 123-30.
22. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A,. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007; 110: 267-78.
23. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R,. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008; 199: 435.e1-7.
24. Krafft A, Breymann C,. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. J Obstet Gynaecol Res 2011; 37: 119-24.